Impact of human immunodeficiency virus on survival after liver transplantation: Analysis of united network for organ sharing database

Transplantation

Volumn 85, Issue 3, 2008, Pages 359-368

  Mindikoglu, Ayse L ^a   Regev, Arie ^b   Magder, Laurence S ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Coinfection; HAART; Hepatitis B; Hepatitis C; MELD

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; DATA BASE; FEMALE; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER DISEASE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; PRIORITY JOURNAL; SCORING SYSTEM;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL SPECIMEN BANKS; CHILD; CHILD, PRESCHOOL; FEMALE; HIV; HUMANS; INFANT; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; RISK FACTORS; SURVIVAL RATE;

EID: 40049109390     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181605fda     Document Type: Article

References (36)

1. Towards universal access by 2010: How WHO is working with countries to scale-up HIV prevention, treatment, care and support. Available at: http://www.who.int/hiv/toronto2006/UAreport2006_en.pdf. Accessed May 13, 2007.
2. Spotlight: Commemorating 25 years of HIV/AIDS. Available at: http://www.cdc.gov/hiv/25.htm. Accessed May 13, 2007.
3. Consensus statement on indications for liver transplantation: Paris, June 22-23, 1993. Hepatology 1994; 20: 63S.
4. Tzakis AG, Cooper MH, Dummer JS, Ragni M, Ward JW, Starzl TE. Transplantation in HIV patients. Transplantation 1990; 49: 354.
5. Bouscarat F, Samuel D, Simon F, Debat P, Bismuth H, Saimot AG. An observational study of 11 French liver transplant recipients infected with human immunodeficiency virus type 1. Clin Infect Dis 1994; 19: 854.
6. Erice A, Rhame FS, Heussner RC, Dunn DL, Balfour HH Jr. Human immunodeficiency virus infection in patients with solid-organ transplants: Report of five cases and review. Rev Infect Dis 1991; 13: 537.
7. Wong KH, Chan KC, Lee SS. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy. Clin Infect Dis 2004; 39: 853.
8. Fung J, Eghtesad B, Patel-Tom K, DeVera M, Chapman H, Ragni M. Liver transplantation in patients with HIV infection. Liver Transpl 2004; 10: S39.
9. Sulkowski MS, Mast EE, Seeff LB, Thomas DL. Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus. Clin Infect Dis 2000;30 (suppl 1): S77.
10. Makris M, Preston FE, Triger DR, et al. Hepatitis C antibody and chronic liver disease in haemophilia. Lancet 1990; 335: 1117.
11. Rustgi VK, Hoofnagle JH, Gerin JL, et al. Hepatitis B virus infection in the acquired immunodeficiency syndrome. Ann Intern Med 1984; 101: 795.
12. Bica I, McGovern B, Dhar R, et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 2001; 32: 492.
13. Charlton M, Seaberg E, Wiesner R, et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998; 28: 823.
14. Berenguer M, Prieto M, San Juan F, et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 2002; 36: 202.
15. Soto B, Sanchez-Quijano A, Rodrigo L, et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 1997; 26: 1.
16. de Vera ME, Dvorchik I, Tom K, et al. Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C. Am J Transplant 2006; 6: 2983.
17. Prachalias AA, Pozniak A, Taylor C, et al. Liver transplantation in adults coinfected with HIV. Transplantation 2001; 72: 1684.
18. Neff GW, Bonham A, Tzakis AG, et al. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transpl 2003; 9: 239.
19. Neff GW, Sherman KE, Eghtesad B, Fung J. Review article: Current status of liver transplantation in HIV-infected patients. Aliment Pharmacol Ther 2004; 20: 993.
20. Cengiz C, Park JS, Saraf N, Dieterich DT. HIV and liver diseases: Recent clinical advances. Clin Liver Dis 2005; 9: 647-666, vii.
21. Ragni MV, Eghtesad B, Schlesinger KW, Dvorchik I, Fung JJ. Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease. Liver Transpl 2005; 11: 1425.
22. Fishman JA. Transplantation for patients infected with human immunodeficiency virus: No longer experimental but not yet routine. J Infect Dis 2003; 188: 1405.
23. Samuel D, Duclos-Vallee JC, Teicher E, Vittecoq D. Liver transplantation in patients with HIV infection. J Hepatol 2003; 39: 3.
24. Samuel D, Duclos-Vallee JC. The difficulty in timing for liver transplantation in cirrhotic patients coinfected with HIV: In search for a prognosis score. Liver Transpl 2006; 12: 699.
25. Terrault NA, Carter JT, Carlson L, Roland ME, Stock PG. Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation. Liver Transpl 2006; 12: 801.
26. BMI classification. Available at: http://www.who.int/bmi/index.jsp? introPage=intro_3.html. Accessed April 14, 2007.
27. Kleinbaum DG Kupper L, Morgenstern H, eds. Epidemiologic research: Principles and quantitative methods. Belmont, CA, Lifetime Learning Publications 1982, p 529.
28. Castells L, Escartin A, Bilbao I, et al. Liver transplantation in HIV-HCV coinfected patients: A case-control study. Transplantation 2007; 83: 354.
29. Antiretroviral regimens recommended for treatment of HIV-1 infection in antiretroviral naïve patients. Available at www.uptodate.com. Accessed May 10, 2007.
30. Izzedine H, Launay-Vacher V, Baumelou A, Deray G. Antiretroviral and immunosuppressive drug-drug interactions: An update. Kidney Int 2004; 66: 532.
31. Jain AB, Venkataramanan R, Eghtesad B, et al. Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in liver transplantation patients. Liver Transpl 2003; 9: 954.
32. Uberti-Foppa C, De Bona A, Morsica G, et al. Pretreatment of chronic active hepatitis C in patients coinfected with HIV and hepatitis C virus reduces the hepatotoxicity associated with subsequent antiretroviral therapy. J Acquir Immune Defic Syndr 2003; 33: 146.
33. O'Grady J, Taylor C, Brook G. Guidelines for liver transplantation in patients with HIV infection (2005). HIV Med 2005;6 (suppl 2): 149.
34. Norris S, Taylor C, Muiesan P, et al. Outcomes of liver transplantation in HIV-infected individuals: The impact of HCV and HBV infection. Liver Transpl 2004; 10: 1271.
35. Ragni MV, Belle SH, Im K, et al. Survival of human immunodeficiency virus-infected liver transplant recipients. J Infect Dis 2003; 188: 1412.
36. Silberhumer GR, Pokorny H, Hetz H, et al. Combination of extended donor criteria and changes in the Model for End-Stage Liver Disease score predict patient survival and primary dysfunction in liver transplantation: A retrospective analysis. Transplantation 2007; 83: 588.